A REVIEW OF LEVER CARE

Choose other agents are encouraged as choice brokers based upon administration troubles and/or adverse impact profile.  Zidovudine combined with lamivudine is the alternative NRTI backbone but is linked to much more hematologic toxicity. Lopinavir/ritonavir is another PI agent with founded safety but reveals greater gastrointestinal intolerance.[e